V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220015087 | 220021034 | 1.64 | 60 | Palliative (P) | 2014-09-15 | 2014-09-18 | DABRAFENIB + TRAMETINIB | N | N | 220022881 | MITOXANTRONE + TRETINOIN |
| 220015088 | 220009745 | 1.7 | 112 | Curative (C) | 2016-08-26 | 2016-10-07 | Carboplatin AUC 6 - 10 | N | N | 220022925 | VINCRISTINE |
| 220015089 | 220009746 | 1.39 | 81 | Curative (C) | 2013-10-23 | 2013-10-25 | CHOP R - 21 days | N | N | 220023120 | BUSULFAN + CYCLOPHOSPHAMIDE |
| 220015090 | 220009747 | 1.64 | 67.3 | null | 2015-05-06 | 2015-05-06 | Carboplatin AUC 6 - 10 | null | null | 220023457 | CAPECITABINE |
| 220015091 | 220009748 | null | 103 | null | 2013-04-13 | 2013-05-28 | CTD | 99 | N | 220023457 | BENDAMUSTINE + RITUXIMAB |
| 220015092 | 220009749 | null | null | null | 2016-05-21 | 2016-06-02 | CISPLATIN + RT | N | N | 220023979 | MELPHALAN |
| 220015093 | 220009751 | 1.66 | 65.8 | Curative (C) | 2014-08-02 | 2014-08-03 | PEMBROLIZUMAB | N | N | 220024165 | SUNITINIB |
| 220015094 | 220009752 | null | 84.3 | null | 2017-02-14 | 2017-06-23 | Carboplatin AUC 2 - 5 | null | null | 220025308 | ARSENIC TRIOXIDE |
| 220015095 | 220009752 | 1.68 | 77 | Curative (C) | 2014-07-06 | 2014-07-06 | CYTARABINE + FLUDARABINE + IDARUBICIN | null | N | 220025308 | CYTARABINE + METHOTREXATE |
| 220015096 | 220009754 | 1.52 | 89 | Curative (C) | 2019-07-26 | 2019-08-03 | Carboplatin AUC 2 - 5 | N | N | 220026026 | DABRAFENIB |
| 220015097 | 220009755 | 1.67 | 69.1 | Curative (C) | 2018-10-05 | 2018-10-20 | CAPECITABINE + OXALIPLATIN | N | N | 220026216 | ARSENIC TRIOXIDE + ATRA |
| 220015098 | 220009757 | 1.69 | 73.8 | Curative (C) | 2016-05-30 | 2016-05-30 | FIGARO TRIAL | N | N | 220026351 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220015099 | 220009758 | 1.65 | 0 | Curative (C) | 2017-04-10 | 2017-04-10 | Cisplatin + Radiotherapy | 01 | N | 220026615 | MERCAPTOPURINE |
| 220015100 | 220009758 | null | null | Disease modification (D) | null | 2018-04-12 | FLUDARABINE | null | null | 220026615 | MELPHALAN |
| 220015101 | 220009758 | 1.82 | 166.7 | Curative (C) | 2018-04-13 | 2018-09-03 | IPILIMUMAB + NIVOLUMAB | N | N | 220026615 | DABRAFENIB |
| 220015102 | 220015139 | 1.69 | 58.5 | Palliative (P) | 2017-11-13 | 2017-11-27 | Cytarabine+Methotrexate Intrathecal | 2 | N | 220027021 | IPILIMUMAB + NIVOLUMAB |
| 220015103 | 220009760 | 1.77 | 68 | Disease modification (D) | 2018-10-08 | 2018-10-23 | EOX | 02 | N | 220027094 | ETOPOSIDE |
| 220015104 | 220009761 | 1.7 | 91.7 | Disease modification (D) | null | 2018-07-18 | Etoposide IV | 2 | N | 220027282 | CLADRIBINE |
| 220015105 | 220015140 | 1.76 | 57.6 | Curative (C) | 2017-01-22 | 2017-01-31 | Arsenic trioxide | N | N | 220027282 | CAPECITABINE + OXALIPLATIN |
| 220015106 | 220009762 | 1.72 | 0 | Palliative (P) | 2016-05-03 | 2016-07-11 | LENALIDOMIDE | N | N | 220027500 | UKALL2011 |
| 220015107 | 220009763 | 1.8 | null | Curative (C) | 2015-08-22 | 2015-12-08 | Alemtuzumab+Busulfan+CyclophosphMUD | null | null | 220027517 | CAPECITABINE |
| 220015108 | 220009764 | 1.64 | 76 | Curative (C) | 2017-02-19 | 2017-03-06 | Y-90 | 2 | N | 220027666 | MIDAC |
| 220015109 | 220009766 | null | null | Curative (C) | 2014-09-08 | 2014-09-27 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 220027883 | EOX |
| 220015110 | 220015142 | 1.86 | 81.2 | Curative (C) | 2018-04-22 | 2018-07-01 | Doxorubicin + Ifosfamide | N | N | 220027990 | CETUXIMAB + IRINOTECAN + MDG |
| 220015111 | 220015142 | null | null | Curative (C) | 2018-07-11 | 2018-07-11 | Busulfan po + Fludarabine RIC Allo | N | N | 220027990 | CAV |
| 220015112 | 220009767 | 1.54 | 80.5 | Palliative (P) | 2018-05-15 | 2018-05-28 | IPILIMUMAB + NIVOLUMAB | 02 | N | 220028561 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 220015113 | 220015143 | 1.7 | 82.5 | Curative (C) | null | 2015-11-17 | CISPLATIN + RT | N | N | 220028611 | CYTARABINE + IDARUBICIN |
| 220015114 | 220009768 | 1.79 | 119.4 | null | 2015-05-24 | 2015-08-18 | MELPHALAN | null | null | 220028693 | ARSENIC TRIOXIDE |
| 220015115 | 220009768 | 1.75 | 23.8 | Curative (C) | 2016-12-22 | 2016-12-22 | PERM Trial | 02 | N | 220028693 | CYTARABINE + IDARUBICIN |
| 220015116 | 220020013 | 1.57 | 67.3 | null | 2018-02-27 | 2018-03-19 | CETUXIMAB | 02 | N | 220028838 | EOX |
| 220015117 | 220009769 | 0 | 82 | null | 2018-01-21 | 2018-02-28 | LIPOSOMAL DOXORUBICIN | N | null | 220029019 | CARBOPLATIN |
| 220015118 | 220015145 | 1.67 | 44.8 | Palliative (P) | 2016-11-13 | 2016-12-05 | Ipilimumab | 02 | N | 220029097 | GCLAC |
| 220015120 | 220009771 | 1.62 | 80.6 | Disease modification (D) | 2014-09-17 | 2014-10-09 | Abiraterone | 2 | N | 220029136 | FIGARO TRIAL |
| 220015121 | 220009772 | 1.7 | null | null | 2018-02-23 | 2018-02-23 | Capecitabine (21days) + Carboplatin | N | N | 220029150 | CARBOPLATIN + CETUXIMAB + FU |
| 220015122 | 220009772 | 1.63 | 60 | Curative (C) | 2018-02-24 | 2018-02-26 | Eribulin | N | N | 220029150 | SORAFENIB |
| 220015123 | 220009772 | null | 83.6 | null | 2019-02-06 | 2019-03-16 | MELPHALAN | N | N | 220029150 | MITOXANTRONE + TRETINOIN |
| 220015124 | 220009775 | null | 116.3 | null | 2017-04-14 | 2017-04-27 | Methotrexate High Dose (3g/m2) | N | N | 220029686 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220015125 | 220015149 | 1.55 | 68.3 | Neo-adjuvant (N) | null | 2014-12-08 | Capecitabine + Oxaliplatin 21day | 02 | N | 220029875 | IPILIMUMAB + NIVOLUMAB |
| 220015126 | 220015149 | 1.84 | 89 | Palliative (P) | 2015-10-01 | 2015-10-01 | BUSULFAN + CYCLO | 02 | N | 220029875 | RAVVA TRIAL |
| 220015127 | 220015149 | 1.58 | 72.8 | Palliative (P) | 2018-04-05 | 2018-04-05 | Trifluridine + Tipiracil | N | N | 220029875 | IPILIMUMAB |
| 220015128 | 220009777 | 1.63 | null | null | 2014-07-03 | 2017-11-07 | Capecitabine + Oxaliplatin 21day | N | N | 220031025 | METHOTREXATE HIGH DOSE |
| 220015129 | 220015150 | 1.68 | 61.4 | null | 2013-07-29 | 2014-01-17 | LIPOSOMAL DOXORUBICIN | 2 | Y | 220031025 | TEMOZOLOMIDE + RT |
| 220015130 | 220020016 | 1.83 | 86.5 | Curative (C) | 2017-03-29 | 2017-04-09 | CAMELLIA Trial | N | N | 220031271 | CISPLATIN + ETOPOSIDE |
| 220015131 | 220009778 | null | 30.05 | Neo-adjuvant (N) | 2017-05-04 | 2017-05-05 | CVAD | null | N | 220031497 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 220015132 | 220009780 | 1.73 | 23.7 | Palliative (P) | 2014-07-15 | 2014-07-15 | Y-90 | N | N | 220031627 | MERCAPTOPURINE |
| 220015133 | 220009781 | null | 65.099 | Palliative (P) | 2017-04-20 | 2017-05-09 | Bendamustine + prednisolone | N | N | 220031627 | CARBOPLATIN |
| 220015134 | 220009784 | 1.78 | 92 | null | 2018-04-30 | 2018-05-28 | Pazopanib | 2 | N | 220032395 | RALTITREXED |
| 220015135 | 220009787 | 1.64 | 79.7 | Curative (C) | 2016-04-04 | 2016-04-04 | PEMBROLIZUMAB | N | Y | 220032395 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220015136 | 220009789 | null | 65.7 | Palliative (P) | 2016-12-19 | 2017-06-08 | Capecitabine + Oxaliplatin 21day | 02 | N | 220033190 | PAZOPANIB |
| 220015137 | 220009789 | 1.64 | 47.4 | null | 2015-08-14 | 2015-08-20 | Bevacizumab 7.5mg/kg | 2 | N | 220033190 | IPM |